Leukocyte-derived cytokine

Leukocyte-derived cytokines refer to a broad group of small regulatory proteins produced and secreted by various types of white blood cells (leukocytes), including lymphocytes (T and B cells), monocytes, macrophages, and neutrophils[5][6]. Rather than being a single molecule or specific receptor, this term encompasses many individual signaling proteins such as interleukins, interferons, chemokines, and colony-stimulating factors. These cytokines orchestrate critical immune responses—including inflammation, cell trafficking, cell survival, maturation, and repair—by acting through dedicated cytokine receptors on target cells[1][4][5][6]. They mediate both pro-inflammatory and anti-inflammatory effects and are implicated in a wide range of diseases. Because "leukocyte-derived cytokines" is not a single molecular entity but a functional category, it is not considered a conventional therapeutic target; instead, therapeutic intervention generally focuses on individual cytokines or their receptors. Key reasoning: - "Leukocyte-derived cytokines" is a broad descriptive category, not a single protein, gene, or receptor and cannot be specifically targeted in the way individual cytokines or their receptors can[1][4][5][6]. - There is a therapeutic interest in many leukocyte-derived cytokines (e.g., IL-1, IL-6, TNF-α), but the entry as requested is not a valid canonical molecular target; each cytokine within this group would need separate, specific entries[1][4][5][6]. - "Leukocyte-derived cytokines" is therefore not technically a molecular target; its use in search or curation implies incorrect or overly broad target definition—hence, is_incorrect: true.

Other names

Cytokines derived from leukocytesImmune cell–derived cytokinesWhite blood cell–derived cytokines